May 17, 2017 12:04 pm UTC| Business
VANCOUVER, British Columbia, May 17, 2017 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) a leader in developing functionally and nutritionally valuable plant-based proteins, is pleased to announce...
May 17, 2017 12:04 pm UTC| Business
VANCOUVER, British Columbia, May 17, 2017 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) a leader in developing functionally and nutritionally valuable plant-based proteins, is pleased to announce...
May 17, 2017 12:04 pm UTC| Business
VANCOUVER, British Columbia, May 17, 2017 -- Burcon NutraScience Corporation (TSX:BU) (NASDAQ:BUR) (“Burcon”) a leader in developing functionally and nutritionally valuable plant-based proteins, is pleased to announce...
May 17, 2017 12:04 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 17, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced an upcoming...
May 17, 2017 12:04 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 17, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced an upcoming...
May 17, 2017 12:04 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 17, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced an upcoming...
May 17, 2017 12:04 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., May 17, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, today announced an upcoming...
Mother of All Deals: India & EU Seal Historic FTA After 20 Years